La maladie de Rendu-Osler : un facteur de risque d’infection ostéoarticulaire à ne pas méconnaître
Tài liệu tham khảo
Shovlin, 2010, Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment, Blood Rev, 24, 203, 10.1016/j.blre.2010.07.001
McDonald, 2011, Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis, Genet Med, 13, 607, 10.1097/GIM.0b013e3182136d32
Shovlin, 2000, Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome), Am J Med Genet, 91, 66, 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P
Dupuis-Girod, 2012, Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output, JAMA, 307, 948, 10.1001/jama.2012.250
Dupuis-Girod, 2007, Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association, Clin Infect Dis, 44, 841, 10.1086/511645
Duval, 2001, Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease), Am J Med, 110, 671, 10.1016/S0002-9343(01)00709-4
Cirulli, 2006, Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT, Curr Pharm Des, 12, 1209, 10.2174/138161206776361336
McAllister, 1994, Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1, Nat Genet, 8, 345, 10.1038/ng1294-345
Johnson, 1996, Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2, Nat Genet, 13, 189, 10.1038/ng0696-189
Ashcroft, 1999, Bidirectional regulation of macrophage function by TGF-beta, Microbes Infect, 1, 1275, 10.1016/S1286-4579(99)00257-9
2009